Supplementary Figure S9 from Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy | Synapse
October 2, 2025Open Access
Supplementary Figure S9 from Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy
Key Points
The study identifies gene expression patterns that indicate a favorable prognosis for patients with bladder cancer after treatment.
Key findings show that certain cancer-associated markers express differently on frequently altered chromosomes in muscle-invasive bladder cancer.
Analysis focuses on the gene expression of markers significantly linked to muscle-invasive bladder cancer, using transcriptomic data.
These insights may help refine treatment strategies and improve prognostic assessments in bladder cancer patients.
Abstract
Figure S9: Gene expression of select cancer-associated markers located on chromosomes frequently altered in muscle-invasive bladder cancer.